ACTIVE

Alcon Laboratories Belgium

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result4,4 M €+9,8 %over 1 year

Revenue169,7 M €+2,0 %over 1 year

Equity26,6 M €+19,9 %over 1 year

Workforce401,8 ETP+4,4 %over 1 year

Identity

Source · BCE/KBO

Alcon Laboratories Belgium is a Private limited company incorporated in 2010. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Puurs-Sint-Amands. It employs on average 401,8 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0830.069.679
Incorporation: 04/10/2010
Legal form: Private limited company
Registered office: Lichterveld 3
2870 Puurs-Sint-Amands · FlandreSee on map
Contributed capital: 18 550,00 €
Latest accounts: 31/12/2025
Average workforce: 401,8 ETP

Activities (NACE)

21201Manufacture of pharmaceutical preparations· main 21201Manufacture of pharmaceutical preparations 82990Other business support service activities n.e.c.82990Other business support service activities n.e.c.21201Manufacture of pharmaceutical preparations 21201Manufacture of pharmaceutical preparations+8

Joint committees (2)

Signals

ProfitablePositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 15 filings

Trend over 10 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	169,7 M €	+2.0%	166,5 M €	-3.0%	171,6 M €	+7.5%	159,6 M €	+22.2%	130,6 M €
EBITDA	10,7 M €	+29.2%	8,3 M €	-19.1%	10,3 M €	+4.3%	9,8 M €	+23.8%	8 M €
Operating result	6,1 M €	+6.2%	5,7 M €	-5.7%	6,1 M €	+10.8%	5,5 M €	+23.2%	4,5 M €
Net result	4,4 M €	+9.8%	4 M €	-6.8%	4,3 M €	+17.0%	3,7 M €	+18.1%	3,1 M €
Balance sheet
Equity	26,6 M €	+19.9%	22,2 M €	+22.1%	18,1 M €	+31.2%	13,8 M €	+36.3%	10,1 M €
Total assets	107,2 M €	+20.0%	89,3 M €	+10.3%	80,9 M €	+13.6%	71,2 M €	+22.8%	58 M €
Cash	–		–		–		–		–
Debts	79,7 M €	+19.5%	66,7 M €	+7.4%	62,1 M €	+9.3%	56,8 M €	+19.6%	47,5 M €
Other
Workforce	401,8 ETP	+4.4%	385,0 ETP	-2.3%	394,1 ETP	-2.4%	403,8 ETP	-1.0%	408,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 50 M€ and 100 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 8 ended

Active mandates

Jason Mangum

Director · since 01 décembre 2025

Active

Liesbeth Tack

Director · since 01 août 2024

Active

Gerald Patrick Collier

Director · since 10 juillet 2022 · until 30 novembre 2025

Active

Yannick Cools

Director · since 28 janvier 2021

Active

Ended mandates

Gerald Patrick Collier

Director · since 10 juillet 2022

Ended

Caroline Loquet

Chairman of the board of directors · since 01 janvier 2019 · until 31 juillet 2024

Ended

Caroline Loquet

Chairman of the board of directors · since 01 janvier 2019

Ended

Chris Olson

Director · since 01 janvier 2019

Ended

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	02/07/2026	07/07/2025	25/07/2024	30/06/2023	08/07/2022	28/07/2021
General meeting	30/06/2026	30/06/2025	28/06/2024	30/06/2023	08/07/2022	09/07/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 15 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	30/06/2026	02/07/2026	Dutch	PDF
Full model	31/12/2024	30/06/2025	07/07/2025	Dutch	PDF
Full model	31/12/2023	28/06/2024	25/07/2024	Dutch	PDF
Full model	31/12/2022	30/06/2023	30/06/2023	Dutch	PDF
Full model	31/12/2021	08/07/2022	08/07/2022	Dutch	PDF
Full model	31/12/2020	09/07/2021	28/07/2021	Dutch	PDF
Full model	31/12/2019	26/06/2020	29/06/2020	Dutch	PDF
Full model	31/12/2018	18/10/2019	22/10/2019	Dutch	PDF
Full model	31/12/2017	28/08/2018	26/09/2018	Dutch	PDF
Full model	31/12/2016	30/06/2017	20/07/2017	Dutch	PDF
Full model	31/12/2015	26/04/2016	07/11/2016	Dutch	PDF
Full model	31/12/2014	07/09/2015	01/10/2015	Dutch	PDF
Full model	31/12/2013	27/05/2014	27/06/2014	Dutch	PDF
Full model	31/12/2012	12/09/2013	15/10/2013	Dutch	PDF
Full model	31/12/2011	28/05/2013	15/10/2013	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 50 M€ and 100 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 8 ended

Active mandates

Jason Mangum

Director · since 01 décembre 2025

Active

Liesbeth Tack

Director · since 01 août 2024

Active

Gerald Patrick Collier

Director · since 10 juillet 2022 · until 30 novembre 2025

Active

Yannick Cools

Director · since 28 janvier 2021

Active

Ended mandates

Gerald Patrick Collier

Director · since 10 juillet 2022

Ended

Caroline Loquet

Chairman of the board of directors · since 01 janvier 2019 · until 31 juillet 2024

Ended

Caroline Loquet

Chairman of the board of directors · since 01 janvier 2019

Ended

Chris Olson

Director · since 01 janvier 2019

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Other18/09/2026
Wijziging vaste vertegenwoordiger commissaris
PDF
Mandates16/12/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates24/12/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates13/09/2024
WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
PDF
Mandates27/03/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates23/09/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates04/06/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates04/03/2021
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 20254,4 M €↑
01/12/2025
nominationJason Mangum — bestuurder
2024
Annual accounts 20244 M €↓
03/09/2024
reconductionCOOLS Yannick Arlette Albert — bestuurder
03/09/2024
reconductionCOLLIER Gerald Patrick — bestuurder
03/09/2024
nominationTACK Liesbeth Marie Hector — niet-statutaire bestuurder
03/09/2024
nominationCOOLS Yannick Arlette Albert — lid van de Groep A
03/09/2024
nominationGORDTS Hans Emiel — lid van de Groep B
03/09/2024
nominationHERMANS Hilde Josee Paula — lid van de Groep B
03/09/2024
nominationVAN DYCK Louis Leon Lieve — lid van de Groep B
28/06/2024
nominationSofie Van Grieken — commissaris
2023
Annual accounts 20234,3 M €↑
23/02/2023
nominationHilde Hermans — externe vertegenwoordiger behorende tot de groep B
23/02/2023
nominationLouis Van Dyck — externe vertegenwoordiger behorende tot de groep B
2022
Annual accounts 20223,7 M €↑
10/07/2022
nominationGerald Patrick Collier — bestuurder
2021
Annual accounts 20213,1 M €↓
2020
Annual accounts 20203,2 M €↓
2019
Annual accounts 20193,8 M €↑
2017
Annual accounts 20171,8 k €↓
2016
Annual accounts 20161,8 k €↑
2015
Annual accounts 20151,6 k €
04/10/2010
IncorporationPrivate limited company

Alcon Laboratories Belgium

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline